Hot Lime Labs is an early-stage tech Kiwi company in the growing Booster Innovation Fund (BIF) portfolio, who are breaking new ground by challenging industrial norms.
A leading supplier of avocados and citrus in the New Zealand market, Darling Group is a family-run company providing fresh produce from local and international suppliers to major supermarkets year round.
Amaroq Therapeutics, part of NZ Innovation Booster's portfolio, has secured $14 million in backing to help develop a new kind of targeted cancer drug in the emerging field of RNA therapy.
An FMA report reveals younger people were more likely to switch to a lower risk fund during COVID-19 market volatility without understanding the long-term impact of their decision.
Booster joined an initiative led by the NZ Super Fund, calling on social media companies to do more to prevent their platforms being used to disseminate objectionable material.
NZ Innovation Booster invests in a number of exciting research and innovative start-ups, helping fund the ground-breaking research to the next level – while keeping IP right here in NZ - one exciting innovation is Inhibit Coatings.
Global share markets have continued to bounce back from the big sell off in March, as investors started looking ahead to the gradual lifting of restrictions around the world.
There’s no question that New Zealand’s wine industry is one of our biggest industries. Our wine is exported across the globe, and considered to be amongst some of the finest in the world.
Find out what we have been busy doing behind the scenes with lots of exciting new features and products for mybooster - including the new and improved mybooster!
Concerned about market activity and your KiwiSaver balance? Wondering what the best course of action is to take? It will depend on your investment timeframe and savings goals.
Alison Payne, Booster's Chief Operating Officer, discusses how Booster's Private Land and Property Fund is an alternative to traditional property investments, while investing back into New Zealand land and property.
The New Zealand Innovation Booster announces its latest funding investment for a potentially ground-breaking Multiple sclerosis drug, being developed by Rekover Therapeutics.
Paul Foley, Chairman of Booster, explains why investing in PLPF is a good addition to your nest egg if you're looking for something that offers more than standard term deposits.
Recently Dan from Booster had the pleasure of flying up to the sunny Bay of Plenty to visit Motiti Island to join the winners of our ‘Win a trip to Motiti Island’ competition.
